Organ-targeted metal-complex catalysis within living biological systems

February 17, 2017, Wiley
Organ-targeted metal-complex catalysis within living biological systems

Address and deliver: A gold catalyst can be delivered to a target organ in a higher organism where it performs a chemical transformation visualized by bioimaging. This intriguing approach has been introduced by a Japanese team of scientists in the journal Angewandte Chemie. It could make organometallic catalysis applicable for therapy or diagnostics.

How is a therapeutically useful catalyst guided into its to synthesize bioactive molecules and drugs in higher level? How can its activity be visualized there? Noninvasive targeting for therapy, biological sensing, and imaging has become one of the most active biomedical research areas. Katsunori Tanaka and his colleagues at RIKEN, Waseda University, and JST-PRESTO (Japan) and Kazan Federal University (Russia) are especially interested in biocompatible metal complexes and, among them, gold catalysts to perform synthetic transformations in a target tissue. The challenge, however, is to bring the gold specifically to its target organ and to establish a visualization scheme to monitor the ongoing biochemical transformation.

Gold ions can be conjugated to a hydrophobic protein ligand, and this complex can be bound to albumin, an abundant water-soluble protein. The albumin is then furnished with sugar-type molecules, the glycans, which carry the chemical groups responsible for glycoalbumin accumulation in a target organ: "This work explores the adaptation and usage of organ-targeting glycans as biologically-compatible metal carriers," the scientists wrote. Thus the glycoalbumin can deliver the biocompatible metal catalyst, namely the gold complex. Intriguingly, this gold complex efficiently acts as an organometallic catalyst that can perform the reaction between biologically relevant molecules and organic substrates, which means it could be a relevant drug or diagnostic compound.

The scientists used the gold complex to bind a fluorescent dye to certain surface proteins present in the target tissue, which was either the liver or the intestine. To visualize the reaction, they performed fluorescent imaging of the whole living mouse. Within two hours after the injection of the catalyst and the substrate (the functionalized fluorescent dye) into the blood circuit, strong fluorescence in the two organs demonstrated successful in vivo gold catalysis. Thus, a catalytically active gold complex was sent and delivered to a target organ within a short time and without the laborious development of antibodies. As an outlook the scientists envisage biomedical applications, especially for metal catalysts with their unique reactivities: "Example therapies may include uncaging of active, cancer therapeutic enzymes selectively at tumor sites or [...] reactions to produce active drug molecules at targeted organs," they wrote.

Explore further: Chemists create switchable gold catalyst

More information: Kazuki Tsubokura et al. In Vivo Gold Complex Catalysis within Live Mice, Angewandte Chemie International Edition (2017). DOI: 10.1002/anie.201610273

Related Stories

Chemists create switchable gold catalyst

September 23, 2015

A gold catalyst whose behaviour can be controlled by the addition of acid or metal ion cofactors has been designed by chemists from the University of Southampton.

Improving catalysis through nanoconcentrator systems

January 13, 2016

A group of scientists at the University of Amsterdam (UvA) has developed a new approach in enhancing catalytic performance. In the current issue of Nature Chemistry they present functionalised, self-assembled nanospheres ...

Glycocluster design could lead to targeted drug delivery

November 28, 2016

A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes—clusters of sugar chains attached to proteins or lipids—in a way that allows ...

Molecular wave of nanosized metal oxide catalyst

May 24, 2016

Metal oxides represent primary source of catalytic materials for a variety of industrial and research applications, either as an active phase or as a supporting phase. A mechanistic study has revealed the formation of catalytically ...

Recommended for you

Identifying 'designer' drugs taken by overdose patients

March 19, 2018

Drug overdoses are taking a huge toll on public health, with potent synthetic drugs posing a particular threat. Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they're hampered ...

The Swiss army knife of smoke screens

March 18, 2018

Setting off smoke bombs is more than good fun on the Fourth of July. The military uses smoke grenades in dangerous situations to provide cover for people and tanks on the move. But the smoke arms race is on. Increasingly, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.